Navigation Links
Genomma Lab Internacional Announces Third Quarter 2009 Results

MEXICO CITY, Oct. 26 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB) ("Genomma Lab" or "the Company"), announced today its results for the quarter ended September 30, 2009. All figures included herein were prepared in accordance with Mexican GAAP; figures are stated in nominal Mexican pesos. Also, the following consolidated figures show the Company's Spanish operations reclassified as discontinued operations according to Mexican GAAP.

3Q09 Highlights (vs. 3Q08)

  • During the third quarter of 2009, the Company launched Primer Nivel Por Tu Salud generic pharmaceuticals brand; the launch included 167 medical prescription ("RX") and over the counter pharmaceuticals ("OTC") products.
  • Also, during the third quarter, Genomma Lab signed a strategic alliance agreement with Grupo Televisa S.A.B. de C.V. (NYSE: TV) to market and distribute OTC and personal care products in the U.S. and Puerto Rico.
  • Net Sales for the quarter reached Ps. 1,123.7 million, an increase of 57.9%
  • EBITDA(1) increased 43.6%, to Ps. 296.8 million. This represents a 26.4% margin during the period.
  • Earnings per Share(2) increased 37.5%, to Ps. 1.09.
  • International Net Sales rose 295.9%, to Ps. 187.8 million.
  • During the third quarter, Genomma Lab successfully launched four products under three existing brands (Base Brands(3) and Prior Year Launches(4)) as part of our line extension strategy.
  • The Company also launched six products under four New Brands(5), as part of its new product launch plan during the third quarter.

(1) EBITDA is calculated by adding pre-operative expenses, depreciation and amortization to the operating income.

(2) Earnings per share are for the last 12 months and were calculated using the weighted average of shares outstanding for the period.

(3) As defined below.

(4) As defined below.

(5) As defined below.

Comments from the Chairman and CEO

Mr. Rodrigo Herrera, Chairman and Chief Executive Officer, stated: "We are pleased to report Genomma Lab's third quarter 2009 results, which demonstrate outstanding growth and profitability. We are delighted to see that consumer demand for our products remained strong during the third quarter. We will remain cautious until we are sure that the economic situation, and its effect on products demand, has ended.

"We are particularly excited about the launch of Primer Nivel Por Tu Salud, our generic pharmaceuticals brand, since we believe that the market penetration of the generic pharmaceuticals industry in Mexico remains low and we plan to capitalize on the accelerated growth rates estimated for this industry in the coming years. Also, we believe that we have consolidated our business model and feel ready to enter the U.S. and Puerto Rican markets through our strategic alliance with Televisa.

"We will continue to develop and launch innovative products under premium brands, supported by our continuous advertising strategy to drive growth in revenues, earnings and cash generation."

For the complete version of this earnings report, please visit:

Company Description

Genomma Lab Internacional, S.A.B. de C.V. is one of the fastest growing over-the-counter pharmaceutical and personal care products companies in Mexico. Genomma Lab develops, sells and markets a broad range of premium branded products, many of which are leaders in the categories in which they compete in terms of sales and market share. Through a combination of a successful new products development process, consumer-oriented marketing, a broad retail distribution network and a low-cost, highly flexible operating model.

Genomma Lab's shares are listed on the Mexican Stock Exchange under the ticker symbol "LAB.B" (Bloomberg:

SOURCE Genomma Lab Internacional, S.A.B. de C.V.

SOURCE Genomma Lab Internacional, S.A.B. de C.V.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
(Date:11/24/2015)... The uptake of recently approved and pipeline premium ... of market growth to 2021, says GBI Research ... products for Type 1 Diabetes Mellitus (T1DM), will be a key driver ... . --> The uptake of recently approved and pipeline ... driver of market growth to 2021, says GBI Research ...
(Date:11/24/2015)... , UAE, November 24, 2015   ... and dietician deliver s advice and ...   More than 50% of ... to keep themselves healthy according to the DHA   femMED ... in the UAE    Dubai residents are not ...
(Date:11/24/2015)... Mich. , Nov. 24, 2015  Freudenberg Medical has ... rapid HIV testing outside of medical facilities. ... access to medical care is sparse. Nevertheless, prompt diagnosis is ... further spread of the virus. With the help of a ... go from village to village in affected areas and perform ...
Breaking Medicine Technology:
(Date:11/24/2015)... ... November 25, 2015 , ... ... solutions for drugs, biologics, consumer health and global clinical supply services, today announced ... upcoming Clinical Trial Supply East Asia Conference, to be held at the InterContinental ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... ... that the organization will waive paid entry and parking fees at several of ... and Monument Mountain in Great Barrington in support of REI’s Black Friday #OptOutside ...
(Date:11/24/2015)... ... 24, 2015 , ... The American Association of Poison Control ... centers through donations on Tuesday, Dec. 1, 2015. Since 2012, the Tuesday following ... people to collaborate in improving their local communities and help give back in ...
(Date:11/24/2015)... ... ... , LLC launched their Pro Vest, the latest version of their widely popular weight loss ... 10 hours. , The campaign, which will continue to run through Saturday, ... , The PRO Vest provides consumers with a less expensive, one-size fits all comfort option, ...
(Date:11/24/2015)... San Diego, CA (PRWEB) , ... November 24, ... ... and the Silver&Fit® Exercise and Healthy Aging Program have announced ... provider referral service. , “American Specialty Health Fitness is proud to have the ...
Breaking Medicine News(10 mins):